Abbott (NYSE:ABT) announced today that it launched an upgraded version of its NeuroSphere myPath digital health app.
The Abbott Park, Illinois-based company designed the upgraded app with enhanced functionality to help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain.
According to a news release, Abbott’s digital health app can be used on both Apple and Android devices, offering a doctor, their staff and the patient with a shared view of patient-reported outcome measures through each stage of a treatment journey while trying a spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy device.
NeuroSphere myPath allows close tracking and documenting of pain through a series of surveys taken virtually at baseline and during the trial period through the app. Questions cover pain intensity, relief, and changes to physical function experienced by the patient, and their overall well-being with and without the device throughout the treatment.
Following the conclusion of the trial, doctors can receive an end-of-trial report that is both succinct and comprehensive, Abbott said.
The company developed NeuroSphere myPath as part of its family of Neurosphere apps. Abbott Neurosphere apps include the Neurosphere Virtual Clinic which allows patients to receive care anywhere (with cellular or Wi-Fi connection and a sufficiently charged patient controller) by connecting with their doctor via secure, in-app video chat and an integrated remote programming feature.
Neurosphere allows clinicians to prescribe new treatment settings remotely to the patient’s neurostimulation device using the clinician programmer app and a simple and secure remote care connection.
“Our continued advancement of the NeuroSphere myPath app is part of Abbott’s commitment to developing new connected health technology that has the potential to bridge the gap between people and their doctors,” Abbott VP of Neuromodulation Pedro Malha said in the release. “Both the myPath digital app and our NeuroSphere Virtual Clinic allow us to deliver a more personalized and proactive approach to how advanced diseases are managed that are changing how people access healthcare around the world.”